-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Sarepta Therapeutics, Inc. quarterly/annual Current Federal Tax Expense (Benefit) history and change rate from 2017 to 2024.
- Sarepta Therapeutics, Inc. Current Federal Tax Expense (Benefit) for the quarter ending December 31, 2023 was -$3.72M.
- Sarepta Therapeutics, Inc. Current Federal Tax Expense (Benefit) for the twelve months ending December 31, 2023 was $4.18M.
- Sarepta Therapeutics, Inc. annual Current Federal Tax Expense (Benefit) for 2024 was $5.06M, a 21.1% increase from 2023.
- Sarepta Therapeutics, Inc. annual Current Federal Tax Expense (Benefit) for 2023 was $4.18M.
- Sarepta Therapeutics, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was $0.000.
Current Federal Tax Expense (Benefit), Trailing 12 Months (USD)
Current Federal Tax Expense (Benefit), Quarterly (USD)
Current Federal Tax Expense (Benefit), Annual (USD)
Current Federal Tax Expense (Benefit), YoY Annual Change (%)